Decibel Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top 25 shareholders own 73.14% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
19.5%	OrbiMed Advisors LLC	4,945,192	US$24.3m	0%	0.41%
12.4%	Third Rock Ventures, LLC	3,139,685	US$15.4m	0%	5.68%
8.28%	Regeneron Pharmaceuticals, Inc.	2,097,314	US$10.3m	0%	no data
7.15%	BlackRock, Inc.	1,811,483	US$8.9m	0.3%	no data
6.46%	GV Management Company, LLC	1,636,258	US$8.0m	0%	0.82%
4.61%	SR One Capital Management, LP	1,168,663	US$5.7m	0%	2.45%
3.17%	Samsara BioCapital LLC	801,629	US$3.9m	0%	1.51%
2.54%	The Vanguard Group, Inc.	642,325	US$3.2m	0%	no data
1.95%	Bessemer Investment Management LLC	494,071	US$2.4m	0%	no data
1.29%	Harvard Management Company, Inc.	326,029	US$1.6m	-0.84%	0.16%
0.79%	Newtyn Management, LLC	200,000	US$982.0k	-21.2%	0.2%
0.79%	UBS O'Connor LLC	199,200	US$978.1k	5.18%	0.04%
0.63%	Millennium Management LLC	159,224	US$781.8k	-35.4%	no data
0.61%	Bronte Capital Management Pty Ltd	154,878	US$760.4k	-1.64%	0.05%
0.52%	Point72 Asset Management, L.P.	132,010	US$648.2k	-0.42%	no data
0.47%	Bridgeway Capital Management, LLC	119,100	US$584.8k	0%	0.01%
0.46%	Geode Capital Management, LLC	115,567	US$567.4k	0%	no data
0.41%	JP Morgan Asset Management	103,327	US$507.3k	-6.57%	no data
0.23%	Neuberger Berman Investment Advisers LLC	58,800	US$288.7k	275%	no data
0.17%	Acuitas Investments, LLC	41,960	US$206.0k	0%	0.09%
0.16%	State Street Global Advisors, Inc.	40,960	US$201.1k	0%	no data
0.16%	BNY Mellon Asset Management	40,489	US$198.8k	0%	no data
0.14%	Dimensional Fund Advisors LP	34,607	US$169.9k	0%	no data
0.14%	Renaissance Technologies LLC	34,400	US$168.9k	5.85%	no data
0.099%	Atlas Capital Advisors Inc.	25,000	US$122.7k	0%	0.02%